| Wendy Rebecca Klein, LMFT | |
|
380 Massachusetts Ave, Acton, MA 01720-3745 | |
| (978) 266-1991 | |
| Not Available |
| Full Name | Wendy Rebecca Klein |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 380 Massachusetts Ave, Acton, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083899801 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 35001504A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wendy Rebecca Klein, LMFT 380 Massachusetts Ave, Acton, MA 01720-3745 Ph: (978) 266-1991 | Wendy Rebecca Klein, LMFT 380 Massachusetts Ave, Acton, MA 01720-3745 Ph: (978) 266-1991 |
News Archive
Every 40 seconds someone in the U.S. has a stroke, and every four minutes, someone dies from a stroke, according to the U.S. Centers for Disease Control and Prevention (CDC).
Being overweight and resistant to insulin constitute a greater risk for fatty liver than was previously thought, according to a study from Linköping University in Sweden that is now being published in the journal Annals of Medicine.
Care Oncology Clinic, an independent, private organisation providing oncology treatments, announces today the launch of its first clinic on London's Harley Street. Delivered by leading oncologists and palliative care doctors, the clinic is the first of its kind, specifically set up to offer a specialised cancer treatment by targeting the energy requirements of cancer cells using existing medicines that are already licensed for this purpose, have an acceptable safety profile and are low cost. Designed for patients for whom the standard oncology treatment regime is not available, viable, tolerable or providing benefit, this is a new option for treating these cancer patients.
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new ReninSense680(TM) FAST imaging agent for measuring and monitoring a key hypertension and renal disease biomarker in vivo.
The inactivity or "silence" of certain genes plays a fundamental role in the prognosis of acute lymphoblastic leukemia as well as in response to treatment, according to the results of research involving a team made up of specialists from the University Hospital of Navarra and the Center for Applied Medical Research at the same University of Navarra, as well as the Reina Sofía Hospital in Cordoba, Andalusia.
› Verified 4 days ago
Ms. Yuping Nancy Yen, M.S. LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 241 Arlington St, #593, Acton, MA 01720 Phone: 508-641-9989 |